Blood, 130(Suppl 1), 397 LP-397. American Society of Hematology Publons Cavo, M, Hájek, R, Pantani, L, Beksac, M, Oliva, S, Dozza, L, Johnsen, H E, Petrucci, M T, Mellqvist, U-H, Conticello, C, Driessen, C, Marzocchi, G, Dimopoulos, M A, Zweegman, S, Wu, K L, Gamberi, B, Crippa, C, van der Holt, B, Offidani, M, Wester, R, Vincelli, I D, Troia, R, Cornelisse, P, Boccadoro, M & Sonneveld, P 2017, ' Autologous Stem Cell Transplantation Versus Bortezomib-Melphalan-Prednisone for Newly Diagnosed Multiple Myeloma: Second Interim Analysis of the Phase 3 EMN02/HO95 Study ', Blood, vol. 130, no. Suppl 1, pp. 397 LP-397 . < http://www.bloodjournal.org/content/130/Suppl_1/397.abstract >